Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.83p
   
  • Change Today:
    -0.018p
  • 52 Week High: 7.76
  • 52 Week Low: 1.59
  • Currency: UK Pounds
  • Shares Issued: 333.40m
  • Volume: 650,761
  • Market Cap: £6.09m
  • RiskGrade: 328

Regulatory News

Price Monitoring Extension 09-Mar-2023 16:35 RNS
Collaboration with Orano on ImmuPharma Peptide 06-Mar-2023 07:00 RNS
Lupuzor™ Update 06-Feb-2023 07:00 RNS
TR-1: Notification of major holdings 27-Jan-2023 16:25 RNS
TR-1: Notification of major holdings 04-Jan-2023 17:26 RNS
Second Price Monitoring Extn 04-Jan-2023 16:40 RNS
Price Monitoring Extension 04-Jan-2023 16:35 RNS
TR-1: Notification of major holdings 03-Jan-2023 16:58 RNS
Grant of Options 22-Dec-2022 07:55 RNS
End of Year Update 22-Dec-2022 07:00 RNS
Holding(s) in Company 22-Nov-2022 15:15 RNS
Second Price Monitoring Extn 14-Nov-2022 16:40 RNS
Price Monitoring Extension 14-Nov-2022 16:35 RNS
Lupuzor Update 11-Nov-2022 07:31 RNS
Second Price Monitoring Extn 11-Oct-2022 16:40 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.83p
Change Today -0.018p
% Change -0.95 %
52 Week High 7.76
52 Week Low 1.59
Volume 650,761
Shares Issued 333.40m
Market Cap £6.09m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.15% above the market average78.15% above the market average78.15% above the market average78.15% above the market average78.15% above the market average
90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average
Price Trend
90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average
65.08% below the sector average65.08% below the sector average65.08% below the sector average65.08% below the sector average65.08% below the sector average
Income Not Available
Growth
38.27% below the market average38.27% below the market average38.27% below the market average38.27% below the market average38.27% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average

Immupharma Dividends

No dividends found

Trades for 24-Mar-2023

Time Volume / Share Price
16:00 20,359 @ 1.76p
15:24 10,000 @ 1.80p
15:21 5,820 @ 1.82p
15:18 12,000 @ 1.90p
15:08 40,519 @ 1.82p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page